Project: Determining the role of clinical and epigenetic risk markers in dilated cardiomyopathies and heart failure

Acronym DETECTIN-HF (Reference Number: 7. JTC-2016_122)
Duration 01/09/2017 - 31/08/2020
Project Topic Dilated cardiomyopathy is a major cause of heart failure and is the main indication of cardiac transplantation. About 30-50% of the cases can be explained by genetic predisposition. However, the precise mechanisms that lead to variations in disease susceptibility and phenotype presentation including risk for heart failure or sudden cardiac death are thus far unknown. The DETECTIN-HF project will work with selected clinical and molecular markers in a multi-center, multi-national cohort. The facility which arises by creating this single, harmonized portal is unique in setup and scale and is invaluable for research and improved clinical practice.
Network ERA-CVD
Call ERA-CVD Joint Transnational Call 2016

Project partner

Number Name Role Country
1 University Hospital Heidelberg Coordinator Germany
2 University Medical Center Utrecht Partner Netherlands
3 University Hospital Ambroise Paré & Pitié-Salpêtrière Partner France
4 University of Tartu Partner Estonia
5 Institute of Cardiology Partner Poland